Previous studies have demonstrated that MBD1 may contribute to tumorigenesis by binding to hypermethylated CpG islands in the promoters of tumor suppressor genes in cancer cells, for example, in pancreatic cancer [24], lung cancer [19], prostate cancer [25] and leukemia [26] cells. This evidence concerns the gene MBD1 and lung carcinoma.